Pemvidutide is a peptide-based dual receptor agonist that targets both GLP‑1 and glucagon receptors (1:1 balance), designed for once-weekly subcutaneous dosing. It is grouped under the following drug class(es): GLP‑1 Receptor Agonists. The directory classifies it as a clinical API with a peptide source/manufacturing origin. Other names for this substance include ALT‑801, MD‑1373 and SP‑1373. Its PubChem SID is 522838847.
Pemvidutide
| CAS No | 2538014‑94‑5 |
|---|---|
| Molecular Formula | N/A |
| Molecular Weight | 3873.35 g/mol |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pemvidutide is a peptide-based dual receptor agonist that targets both GLP‑1 and glucagon receptors (1:1 balance), designed for once-weekly subcutaneous dosing.
The listed CAS number is 2538014‑94‑5.
The listed molecular formula is N/A.
The listed molecular weight is 3873.35 g/mol.
N/A.
The source lists ALT‑801, MD‑1373 and SP‑1373.